Prot #CT7001_001: A Modular, Multipart, Multi-arm, Open-label, Phase 1/2a Study to Evaluate the Safety and Tolerability of CT7001 Alone and in Combination with Anti-Cancer Treatments in Patients with Advanced Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date10/15/2010/15/23

Funding

  • Emas Pharma Limited (Prot #CT7001_001)
  • Carrick Therapeutics Ltd (Prot #CT7001_001)